ICAP
PTCT icon

Independence Capital Asset Partners’s PTC Therapeutics PTCT Stock Holding History

Independence Capital Asset Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,400
Closed -$156K – 109
2013
Q2 		$156K Buy
+10,400
New +$169K 0.03% 100

Other funds holding PTCT

BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Independence Capital Asset Partners's PTCT Position: Q3 2013 in Review

Independence Capital Asset Partners sold out of PTC Therapeutics (PTCT) in Q3 2013, closing a stake of 10,400 shares — an estimated $156K sold.

Independence Capital Asset Partners first reported a position in PTCT in Q2 2013 and held it in 1 quarter. The position peaked at $156K in Q2 2013. 61 funds tracked by Wall St. Rank hold PTCT as of Q3 2013.

  • Independence Capital Asset Partners reported no remaining PTC Therapeutics position as of Q3 2013 after selling out during the quarter.
  • Independence Capital Asset Partners sold 10,400 PTC Therapeutics shares in Q3 2013, an estimated $156K.
  • Independence Capital Asset Partners first reported a position in PTC Therapeutics in Q2 2013 and held it in 1 quarter.
  • Independence Capital Asset Partners's PTC Therapeutics position peaked at $156K in Q2 2013.
  • 61 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2013.

Based on Independence Capital Asset Partners's 13F filing for Q3 2013, filed 14 Nov 2013.